Literature DB >> 11207969

Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.

A Ozkan1, H Apak, T Celkan, L Yüksel, I Yildiz.   

Abstract

We report a fatal case of toxic epidermal necrolysis (TEN) resulting from a high dose of cytosine arabinoside (ARA-C). A 13-year-old girl with acute lymphocytic leukemia was treated according to the protocol of the BFM Group (BFM-95, HRG). On the fifth day after administration of a high dose of ARA-C (2 g/m2 intravenously every 12 hours), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day. ARA-C is frequently associated with dermatologic toxicity, but this is only the second case of toxic epidermal necrolysis described in connection with this drug.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207969     DOI: 10.1046/j.1525-1470.2001.018001038.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  6 in total

1.  Erythematous eruption in a man with acute myeloid leukemia.

Authors:  Jason Tay
Journal:  CMAJ       Date:  2002-09-17       Impact factor: 8.262

Review 2.  Hypersensitivity reactions to chemotherapeutic drugs.

Authors:  Gillian M Shepherd
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

3.  Life-threatening dermatologic adverse events in oncology.

Authors:  Alyx C Rosen; Yevgeniy Balagula; Dennis W Raisch; Vishvas Garg; Beatrice Nardone; Nicole Larsen; Jennifer Sorrell; Dennis P West; Milan J Anadkat; Mario E Lacouture
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248

4.  Auricular oedema and dyshidrotic eczema in a patient with acute myeloid leukaemia treated with cytarabine.

Authors:  K Brandt; K Schäkel; F Stölzel; J Janschek; G Ehninger; M Schaich
Journal:  Case Rep Oncol       Date:  2010-10-04

Review 5.  Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.

Authors:  Chau Yee Ng; Chun-Bing Chen; Ming-Ying Wu; Jennifer Wu; Chih-Hsun Yang; Rosaline Chung-Yee Hui; Ya-Ching Chang; Chun-Wei Lu
Journal:  J Immunol Res       Date:  2018-01-17       Impact factor: 4.818

6.  A desensitization protocol for delayed allergy to cytarabine: analysis of two cases.

Authors:  Marcello Albanesi; Paola Carluccio; Andrea Nico; Lucia Giliberti; Danilo Di Bona; Maria Filomena Caiaffa; Giorgina Specchia; Luigi Macchia
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.